Salzburg, Austria and Ghent, Belgium – MyCartis, the provider of

fully integrated and broadly applicable molecular diagnostics and immunodiagnostics

solutions, and Sony DADC BioSciences announced the cooperation in the production

of a microfluidic assay cartridge for MyCartis’ EvalutionTM digital multiplex analysis platform to

support a range of applications in the clinical research and pharmaceutical markets and

designed to analyze a broad range of protein and nucleic acid-based biomarkers.

Sony DADC BioSciences, a leading supplier of smart polymer parts for the biomedical

industry, is using their ISO 13485-certified facility in Salzburg, Austria for manufacturing. The

customized foil bonded cartridge is manufactured as a monolithic molded microtiter size plate

that has optical transparency and combines macrostructures, high precision microstructures

and filter structures for achieving the ultra-sensitivity of the EvalutionTM System.

“We are very pleased to be working with Sony DADC BioSciences as our development and

manufacturing partner for the EvalutionTM cartridge. The collaboration between the two

companies brings together a broad range of knowledge and experience, which are important

for the success of innovative new technologies such as the EvalutionTM System,” said Joris

Schuurmans, CEO of MyCartis.

The highly integrated assay cartridge contains reaction and detection chambers to ensure

short time to result and minimal processing steps. Next to the ability to run 1 to 16 samples at

the same time the EvalutionTM System further delivers superior data quality and rapid results.

“We are fascinated about MyCartis’ flexible EvalutionTM platform and enjoy our mutual team

spirit. From a manufacturing perspective, the project enhances our capabilities in both

injection molding and bonding of microfluidic consumables in micro titer plate format – the de

facto industry standard,” said Werner Balika, Engineering Manager at Sony DADC

BioSciences GmbH.

About MyCartis

MyCartis’ innovative research and diagnostic system, called EvalutionTM, features the

measurement and detection of molecular components of different nature (proteins, nucleic

acids…), indicative of a specific pathological state in a multiplex format. The new semiautomated

system is highly user-friendly thanks to its integrated workflow and provides rapid

and robust results thanks to improved kinetics in the microfluidic channels. In addition,

MyCartis develops ready-to-use multiplex assays with major clinical and compelling health

economic values, through its own development efforts as well as through strategic

partnerships. Oncology, neurology, cardiology and immunology are MyCartis’ primary focus.

For more information please visit https://www.mycartis.net/

About Sony DADC BioSciences GmbH

Building on Sony DADC’s experience in high-precision optical disc manufacturing, Sony

DADC BioSciences partners with Life Sciences and Diagnostics companies enabling the

industrial manufacturing of smart polymer parts.

For more information please visit https://biosciences.sonydadc.com